In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adolor Corporation

http://www.adolor.com

Latest From Adolor Corporation

Finance Watch: SPAC Spree To Continue ‘For Foreseeable Future’

Public Company Edition: Merging with a special purpose acquisition corporation may be an attractive alternative to an initial public offering, but February’s vigorous IPO pace includes seven recent offerings that raised $480.8m in the US. Also, Cassava raised $200m and KalVista brought in $222.5m.

Financing Deals

4D Pharma Joins The SPAC Trend To Fund Its Keytruda-Boosting Biotherapeutic

The Leeds, UK-based company is looking to the alternative route to the US stock market to fund its live biotherapeutics platform.

Europe United Kingdom

Class I Recall For Smiths Medical’s Medfusion Syringe Pumps

The device maker recalled more than 46,000 of its Medfusion 3500 and 4000 pumps because a software error can lead to over- or under-dosing.

Recalls Safety

KalVista Reports Positive Phase II Data For Oral HAE Attack Therapy KVD900

The company sees KVD900 as potentially “ideal” for patients using on-demand and prophylactic therapy, given the existing need to carry backup on-demand medications.

Research & Development Research and Development Strategies
See All

Company Information

UsernamePublicRestriction

Register